| 000 | 01662 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517212344.0 | ||
| 264 | 0 | _c20191021 | |
| 008 | 201910s 0 0 eng d | ||
| 022 | _a2045-2322 | ||
| 024 | 7 |
_a10.1038/s41598-018-24662-y _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSampson, Mike | |
| 245 | 0 | 0 |
_aDiscordance in glycemic categories and regression to normality at baseline in 10,000 people in a Type 2 diabetes prevention trial. _h[electronic resource] |
| 260 |
_bScientific reports _c04 2018 |
||
| 300 |
_a6240 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBlood Glucose _xanalysis |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xblood |
| 650 | 0 | 4 |
_aFasting _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlycated Hemoglobin _xanalysis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperglycemia _xdiagnosis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aReproducibility of Results |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aUnited Kingdom |
| 700 | 1 | _aElwell-Sutton, Tim | |
| 700 | 1 | _aBachmann, Max O | |
| 700 | 1 | _aClark, Allan | |
| 700 | 1 | _aDhatariya, Ketan K | |
| 700 | 1 | _aFerns, Clare | |
| 700 | 1 | _aHowe, Amanda | |
| 700 | 1 | _aJohn, W Garry | |
| 700 | 1 | _aRayman, Gerry | |
| 700 | 1 | _aSwafe, Leyla | |
| 700 | 1 | _aTurner, Jeremy | |
| 700 | 1 | _aPascale, Melanie | |
| 773 | 0 |
_tScientific reports _gvol. 8 _gno. 1 _gp. 6240 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/s41598-018-24662-y _zAvailable from publisher's website |
| 999 |
_c28306294 _d28306294 |
||